Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsRecent analysis reveals Epidiolex significantly reduces seizures in patients with various developmental epileptic encephalopathies, showcasing its broad effectiveness.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on autonomic dysfunction in long COVID!
New AES 2025 data reinforce zorevunersen’s disease-modifying potential in Dravet syndrome, showing durable seizure reduction, functional improvements, and a consistent safety profile.
New data highlights cenobamate's effectiveness in reducing focal seizures in Asian populations, showcasing significant improvements and potential long-term benefits for patients.
Multicenter data presented by Silvana Bonilla, MD, at NASPGHAN 2025 highlight regional variation in pediatric H. pylori prevalence and support selective biopsy practices guided by clinical suspicion.
4 Psychiatry Headlines You Missed in November 2025
Low-Grade Proteinuria Not Tied to Improved Renal Outcomes in Lupus Nephritis
1.
The Effect of Common Steroids on Cancer Treatments.
2.
Herpes virus-based vaccine shows promise in targeting tumors without side effects
3.
Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows
4.
After two years, a significant left nasal obstruction was finally diagnosed.
5.
The most precise research tools for the deadliest blood cancer have been developed.
1.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
2.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
5.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation